Proathlete Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Proathlete Wealth Management's LLY Position: Q3 2026 in Review
Proathlete Wealth Management increased its Eli Lilly (LLY) stake by 65% in Q3 2026, buying an estimated $178K and bringing the position to 383 shares worth $444K. The position accounts for 0.1% of the portfolio, ranked #54.
Proathlete Wealth Management first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Proathlete Wealth Management held 383 shares of Eli Lilly worth $444K as of Q3 2026.
- Proathlete Wealth Management bought 151 Eli Lilly shares in Q3 2026, an estimated $178K.
- Eli Lilly made up 0.1% of Proathlete Wealth Management's portfolio in Q3 2026, its #54 holding.
- Proathlete Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
- 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Proathlete Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.